The action of secreted phospholipases A 2 in skin is thought to be essential for epidermal barrier homeostasis. The incomplete knowledge of presence and functions of the novel secreted phospholipase A 2 subtypes in skin prompted us to explore their expression in epidermis and primary keratinocytes from murine neonatal skin. We detected secreted phospholipases A 2 -IB, -IIA, -IIC, -IID, -IIE, -IIF, -V, -X, and -XII. To study secreted phospholipase A 2 expression during epidermal di¡erentiation, primary keratinocytes from the basal, suprabasal, and upper di¡erentiated layers of neonatal mouse epidermis were obtained by density gradient centrifugation. mRNA for secreted phospholipases A 2 -IB, -IIE, -IIF, -V, and -XII-1 are mainly expressed in the upper di¡erentiated layers, whereas the most prominent enzymes in the basal and suprabasal layers are secreted phospholipases A 2 -IIA, -IID, and -X. The mRNA for secreted phospholipase A 2 -IIC was found in all fractions. Immunohistochemical analysis in mouse skin sections re£ected the mRNA distribution patterns in the di¡erent epidermal cell fractions. After in vitro induction of keratinocyte di¡erentiation by increasing the calcium concentration of the medium, secreted phospholipases A 2 -IB, -IIE, -IIF, -V, and -XII-1 were upregulated, whereas secreted phospholipases A 2 -IIA, -IIC, -IID, and -X were mainly expressed in proliferating keratinocytes. The speci¢c secreted phospholipase A 2 expression pro¢le in the skin suggests a distinct function for each enzyme in the epidermis.
The action of secreted phospholipases A 2 in skin is thought to be essential for epidermal barrier homeostasis. The incomplete knowledge of presence and functions of the novel secreted phospholipase A 2 subtypes in skin prompted us to explore their expression in epidermis and primary keratinocytes from murine neonatal skin. We detected secreted phospholipases A 2 -IB, -IIA, -IIC, -IID, -IIE, -IIF, -V, -X, and -XII. To study secreted phospholipase A 2 expression during epidermal di¡erentiation, primary keratinocytes from the basal, suprabasal, and upper di¡erentiated layers of neonatal mouse epidermis were obtained by density gradient centrifugation. mRNA for secreted phospholipases A 2 -IB, -IIE, -IIF, -V, and -XII-1 are mainly expressed in the upper di¡erentiated layers, whereas the most prominent enzymes in the basal and suprabasal layers are secreted phospholipases A 2 -IIA, -IID, and -X. The mRNA for secreted phospholipase A 2 -IIC was found in all fractions. Immunohistochemical analysis in mouse skin sections re£ected the mRNA distribution patterns in the di¡erent epidermal cell fractions. After in vitro induction of keratinocyte di¡erentiation by increasing the calcium concentration of the medium, secreted phospholipases A 2 -IB, -IIE, -IIF, -V, and -XII-1 were upregulated, whereas secreted phospholipases A 2 -IIA, -IIC, -IID, and -X were mainly expressed in proliferating keratinocytes. The speci¢c secreted phospholipase A 2 expression pro¢le in the skin suggests a distinct function for each enzyme in the epidermis. Key words: calcium gradient/epidermal barrier/hyperproliferation/keratinocytes/neonatal mouse. J Invest Dermatol 121: 156^164, 2003 D uring the last few years an increasing number of phospholipases A 2 has been identi¢ed in mammalian tissues (Six and Dennis, 2000; . These enzymes catalyze the hydrolysis of the sn-2 ester bond of phospholipid substrates, thereby producing free fatty acids and lysophospholipids. These products have important roles in physiologic and pathophysiologic processes. Of particular importance are eicosanoids, which are produced from released arachidonic acid and are important mediators of vascular tone and tissue homeostasis, but also of pain and in£ammation. Thus, the knowledge of the expression and regulation of the di¡erent phospholipases A 2 is a prerequisite for understanding their functions in di¡erent organs and tissues and for developing speci¢c inhibitors for therapeutic use.
The di¡erent phospholipases A 2 are classi¢ed into 12 groups (I^XII) and have been characterized in terms of their substrate speci¢cities, Ca 2 þ sensitivity, and cellular location (for reviews see Six and Dennis, 2000; . Using these criteria, the phospholipases A 2 enzymes identi¢ed in mammals have been subdivided into the low molecular weight secreted phospholipases A 2 (sPLA 2 -IB, -IIA, -IIC, -IID, -IIE, -IIF, -III, -V, -X, and -XII), the group IV cytosolic phospholipases A 2 , the group VI Ca 2 þ -independent phospholipases A 2 and the group VII and VIII platelet-activating factor acetyl hydrolases.
Analysis of the expression pattern of the di¡erent sPLA 2 , and in particular of the novel subtypes of secreted phospholipases A 2 has made clear that more than one sPLA 2 s subtype can be expressed in a single tissue or even the same cell, where sPLA 2 s might be localized in di¡erent subcellular compartments (Bingham et al, 1999; Valentin et al, 1999; Degousee et al, 2002) . It is also becoming clear that the mRNA expression of a speci¢c sPLA 2 subtype is not necessarily re£ected by the amount of expressed protein (Schadow et al, 2001; Gelb et al, unpublished observations) .
The increasing diversity of sPLA 2 s leads to a number of questions concerning the functions of these sPLA 2 s in physiologic and pathophysiologic processes.
sPLA 2 s are likely to play a part in normal skin functions. Indeed, sPLA 2 activity is needed for the degradation of polar lipids in the upper epidermal layers for the generation of fatty acids, which, together with ceramides, are major components of the stratum corneum (Elias, 1983; Schˇrer and Elias, 1991) . This layer of apolar lipids is called the permeability barrier, which prevents transepidermal water loss. The physiologic role of one or several sPLA 2 s in barrier integrity became evident from the observation that inhibition of sPLA 2 activity in mouse skin resulted in destruction of the epidermal integrity and in transepidermal water loss (Mao-Qiang et al, 1995 Fluhr et al, 2001 ). sPLA 2 s are probably also involved in in£ammatory processes in the skin, and the knowledge of the expression of sPLA 2 s is important for determining among sPLA 2 s those that are therapeutic targets in skin in£ammation. In support of a pathophysiologic role of the so-called proin£ammatory sPLA 2 -IIA in skin diseases, a transgenic mouse overexpressing the human sPLA 2 -IIA developed hyperkeratosis and hyperplasia, suggesting that human sPLA 2 -IIA may act as a growth factor for keratinocytes (Grass et al, 1996) ; however, murine sPLA 2 -IIA is expressed almost exclusively in small intestine, whereas human sPLA 2 -IIA is expressed in numerous tissues, suggesting that these two enzymes are not functional orthologs of each other (Cupillard et al, 1999, and citations herein) . These results suggest that sPLA 2 s distinct from sPLA 2 -IIA may contribute to murine skin functions and in£ammation.
In a former study, sPLA 2 -IB and sPLA 2 -IIA were identi¢ed in primary mouse keratinocytes as well as in the keratinocyte carcinoma cell line HEL 30 and the possible function of these enzymes in eicosanoid biosynthesis was addressed (Li-Stiles et al, 1998) . Meanwhile several new murine sPLA 2 enzymes have been found in mouse epidermis, although the knowledge of their expression pattern is still incomplete. A recent study has identi¢ed sPLA 2 -IID mRNA in mouse skin , and the expression of sPLA 2 -IID, -IIE, and -IIF was recently found to be upregulated during experimental atopic dermatitis in mouse ears (Murakami et al, 2002a, b, c) . Thus, it is not clear which sPLA 2 subtype is responsible for the fatty acid release described by Li-Stiles et al, 1998; Li-Stiles and Fischer, 1999) or involved in the formation of the permeability barrier. From studies performed in human keratinocytes (Rys-Sikora et al, 2000; Schadow et al, 2001) and in human epidermis in vivo (Maury et al, 2000; MazereeuwHautier et al, 2000) , it can be expected that these enzymes are differentially regulated at the mRNA and protein level depending on the proliferation or di¡erentiation state of the epidermis.
This prompted us to analyze sPLA 2 subtypes expressed at the mRNA and protein levels in the di¡erent stages of development and in the di¡erent layers of the mouse epidermis. A suitable model system to study the expression and function of epidermal sPLA 2 enzymes is the neonatal mouse skin. This system represents a hyperplastic phenotype compared with adult epidermis concerning the morphology, keratin expression, and mitotic activity of the cells from the basal layer (Fˇrstenberger et al, 1985) . Because of its multilayered structure, neonatal epidermis o¡ers the advantage to separate primary keratinocytes by density centrifugation using Percoll gradients to study the pattern of sPLA 2 expression in the di¡erent layers. In the present study, we compared the expression levels of the full set of murine sPLA 2 s in neoplastic skin under proliferating and di¡erentiating conditions by using primary keratinocytes from neonatal skin cultured under low or high Ca 2+ conditions. Moreover, we investigated the pattern of sPLA 2 protein expression in vivo by performing immunohistochemical analysis of neonatal back skin from NMRI mice.
MATERIALS AND METHODS

Preparation of mouse epidermis
Percoll density gradient fractionation of epidermal cells Adult female NMRI mice together with their neonatal 2 to 3 d old o¡spring were purchased from Charles River (Sulzfeld, Germany). Neonatal mouse epidermal cells were obtained by the trypsin £otation method of Yuspa and Harris (1974) . All experiments were carried out according to the guidelines and with permission from the local government of Hessen, Germany. Brie£y, skin of neonatal mice was incubated for 15 h in plastic Petri dishes containing 10 mL of 0.25% trypsin/phosphate-bu¡ered saline (PBS) without Ca 2 þ and Mg 2 þ (Biochrom, Berlin, Germany). The epidermis was then separated from the dermis and thoroughly homogenized. The dissociated cells were loaded onto a Percoll (Fluka, Seelze, Germany) discontinuous gradient ranging from 70% to 30%. Centrifugation at 1900g for 25 min at room temperature yielded four distinct cell fractions with four di¡erent buoyant densities (Fˇrstenberger et al, 1983; Schweizer et al, 1984) . The cell fractions corresponding to the di¡erent layers were removed and collected separately, and Percoll was removed by washing two times with PBS without Ca 2 þ (Invitrogen, Karlsruhe, Germany) with centrifugation at 600g for 18 min at room temperature. Induction of di¡erentiation was con¢rmed by semiquantitative reverse transcription^polymerase chain reaction (reverse transcription^PCR) of involucrin (data not shown).
Ca
2 þ shift For cell culture experiments with primary keratinocytes, cells of the gradient fractions 3 and 4, which represent the proliferative cells of the basal and suprabasal epidermal layers of the mouse epidermis (Fˇrsten-berger et al, 1986; Gross et al, 1987) , were pooled in 4 Â minimal essential medium (Fusenig and Worst, 1974) containing 10% fetal calf serum with 1.0 mM Ca 2 þ . Cells (10 7 ) were seeded in 100 mm cell culture dishes and incubated in high Ca 2 þ medium at 341C. After 4 h the medium was changed to 4 Â minimal essential medium plus 10% fetal calf serum with 0.05 mM Ca 2 þ (low Ca 2 þ medium). After an additional 24 h, the medium was changed to high Ca 2 þ medium. This Ca 2 þ shift procedure is a standardized method to induce di¡erentiation of proliferating keratinocytes (Hennings et al, 1980 (Hennings et al, , 1989 Yuspa et al, 1989) . The cells were harvested as follows: 24 h low Ca 2 þ medium; 8, 24, 48, and 72 h high Ca 2 þ medium. Induction of di¡erentiation was con¢rmed by semiquantitative reverse transcriptionP CR as well as western blot analysis of involucrin (data not shown). The antibody for involucrin was a generous gift from Dr Fiona Watt, Imperial Cancer Research Fund London (UK).
For RNA isolation, the medium was removed, the cells were washed twice with ice-cold PBS, and 400 mL of guanidinium isothiocyanate (Sigma, Munich, Germany) was added to each culture dish. Proteins were extracted from parallel cell culture dishes using 500 mL of homogenization bu¡er (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM phenylmethylsulfonyl £uoride, 10 mg per mL leupeptin), was added.
Di¡erent layers of the neonatal epidermis
The density gradient separated cell fractions, corresponding to the four di¡erent epidermal layers, were prepared as described above. After washing, cells were directly lyzed in guanidinium isothiocyanate for RNA isolation using the guanidinium isothiocyanate/phenol/chloroform method.
Analysis of sPLA 2 mRNA expression by reverse transcription^PCR RNA extraction Total cellular RNA was extracted from the cell pellets using the guanidinium isothiocyanate/phenol/chloroform method. To exclude contamination with DNA, RNA preparations were treated with RNase-free DNase I (Roche Diagnostics, Mannheim, Germany) for 15 min at room temperature before performing reverse transcription^PCR.
Reverse transcription^PCR The expression of mRNA of the di¡erent sPLA 2 subtypes was investigated by reverse transcription^PCR using 5 mg total RNA. As a positive control, poly(A) RNA from various mouse tissues was used (Clontech, Heidelberg, Germany). Negative PCR controls were performed on RNA which were not reverse transcribed. First strand cDNA was transcribed with Superscript II RNase H-RT obtained from Gibco BRL (Karlsruhe, Germany) and Oligo(dT) 15 Primer (Promega, Mannheim, Germany). Aliquots of the ¢rst strand cDNA were taken to perform PCR with the speci¢c primers (Sigma, Karlsruhe, Germany) for each sPLA 2 subtype and RedTaq DNA polymerase (Sigma, Munich, Germany). PCR was performed on a GeneAmp PCR System Thermal Cycler (Amersham Life Science, Freiburg, Germany) using the following primer pairs: Semi-quantitative reverse transcription^PCR For semiquantitative reverse transcription^PCR the number of ampli¢cation steps was tested ¢rst for linearity with di¡erent dilutions of reverse transcription product and di¡erent cycle numbers. Then reverse transcription^PCR for GAPDH was performed so that equivalent amounts of cDNA could be added to individual reaction mixtures. The di¡erent cDNA probes were ampli¢ed in a prepared Mastermix containing deoxyribonucleoside triphosphates, speci¢c primers and RedTaq-polymerase in the corresponding PCR bu¡er.
For the PCR reactions the cycling parameters were optimized as follows: sPLA 2 -IB: 951C for 1 min (1 cycle) followed by 951C for 50 s, 571C for 30 s and 721C for 20 s (39 cycles); sPLA 2 -IIA: 951C for 1 min (1 cycle) followed by 951C for 50 s, 541C for 30 s and 721C for 20 s (40 cycles); sPLA 2 -IIC: 951C for 1 min (1 cycle) followed by 951C for 30 s, 541C for 45 s and 721C for 20 s (34 cycles); sPLA 2 -IID: 951C for 1 min followed by 951C for 50 s, 551C for 30 s and 721C for 20 s. (32 cycles); sPLA 2 -IIE: 951C for 1 min (1 cycle) followed by 951C for 50 s, 571C for 30 s and 721C for 20 s (34 cycles); sPLA 2 -IIF: 951C for 1 min (1 cycle) followed by 951C for 50 s, 571C for 30 s and 721C for 20 s (31 cycles); sPLA 2 -V: 941C for 1 min (1 cycle) followed by 941C for 1 min, 581C for 1 min and 721C for 1 min, 20 s (38 cycles); sPLA 2 -X: 951C for 1 min (1 cycle) followed by 951C for 50 s, 591C for 30 s and 721C for 20 s (38 cycles); sPLA 2 -XII-1: 951C for 1 min (1 cycle) followed by 951C for 50 s, 571C for 30 s and 721C for 20 s (38 cycles); sPLA 2 -XII-2: 941C for 1 min (1 cycle) followed by 941C for 1 min, 541C for 1 min and 721C for 2 min (32 cycles); GAPDH: 941C for 1 min (1 cycle) followed by 941C for 1 min, 601C for 1 min and 721C for 2 min (24 cycles).
The ¢nal extension phase for the PCR reactions of all subtypes was 10 min at 721C. PCR products were separated on 1% agarose gels containing 0.5 mg ethidium bromide per mL and were visualized with an ultraviolet gel camera (Biorad, Munich, Germany). After puri¢cation of the PCR products with a QIAquick PCR puri¢cation kit (Qiagen, Hilden, Germany) the sequences of the di¡erent sPLA 2 enzymes were con¢rmed using a dye terminator DNA sequencing kit in combination with the automated sequence analyzer A310 (Perkin Elmer Applied Biosystems, Weiterstadt, Germany).
Western blot analysis For western blot analysis of sPLA 2 protein expression, cell lysates were obtained as described above. The lysates were soni¢ed for 10 s and centrifugated at 1900g for 5 min at 41C. The supernatants were removed and the protein concentration was measured with the Bradford method. One volume containing 50 mg of cellular protein was precipitated with 0.4 volume of 20% trichloroacetic acid. The protein pellet was diluted in 10 mL Laemmli sample bu¡er under reducing (sPLA 2 -IIA, sPLA 2 -IIF, sPLA 2 -V) or nonreducing (sPLA 2 -IB, sPLA 2 -IID, sPLA 2 -IIE, sPLA 2 -X, sPLA 2 -XII) conditions without boiling, and proteins were separated on a 16% 10 Â 10 cm sodium dodecyl sulfatep olyacrylamide gel. Proteins were transferred to polyvinyldi£uoride membranes (Millipore, Eschborn, Germany) for 40 min at 0.8 mA per cm 2 . The gel was stained with Coomassie blue, to check for e⁄ciency of blotting. Nonspeci¢c binding was blocked with NETG^Bu¡er (150 mM NaCl, 5 mM Ethylenediamine tetraacetic acid, 50 mM Tris/HCl pH 7.5, 0.05% Triton X-100, 0.25% Gelatin) for 30 min at room temperature followed by incubation for 2 h at room temperature with a 1:150 dilution of each primary antibody speci¢c against the corresponding mouse sPLA 2 subtype. The antibodies were generated by immunization of rabbits with the recombinant sPLA 2 proteins. The procedure of the generation of recombinant sPLA 2 enzymes and the antibodies will be described in a following publication by Singer et al and was in principle done as described for the human sPLA 2 enzymes (Degousee et al, 2002) . By blotting de¢ned amounts of each recombinant sPLA 2 protein and performing western blot analyses (see below), it was calculated that each anti-serum is capable of detecting 0.2 to 1 ng of each mouse sPLA 2 (with ECL detection, see below), and does not detect the other mouse sPLA 2 enzymes when 50 ng quantities are applied to the Laemmli gel (not shown). The blots were incubated at room temperature for 1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG (Amersham) at a dilution of 1:10,000. After washing, peroxidase activity was detected by developing the blots by the ECL method (Amersham).
Immunohistochemical analysis Total skin cut from the back of neonatal mice was ¢xed in 4% zinc formalin (Shondon, Pittsburgh, Pennsylvania) for 16 h and then embedded in para⁄n. To study sPLA 2 expression in adult mice, we used cross-sections from the tails, which consist of a comparable multilayered epidermis as the neonatal skin (data not shown).
To investigate the expression of the di¡erent subtypes, 4 mm full thickness biopsies were examined. The para⁄n embedded samples were depara⁄nized two times in xylene for 5 min. Then, rehydration of the sections was performed by sequential incubation in 100% and 96% ethanol (two times each for 10 min), distilled water and equilibration in PBS. The sections were then digested with proteinase K (1.5 mg per mL; Qiagen) for 10 min at room temperature. After washing three times with PBS, samples were blocked for 10 min with serum free blocking bu¡er obtained from DAKO (Hamburg, Germany) followed by an overnight incubation at 41C with the speci¢c rabbit anti-mouse anti-serum (dilution in 2% bovine serum albumin), which were also used for western blotting. The following dilutions were used for the di¡erent sPLA 2 enzymes: sPLA 2 -IB (1:50); sPLA 2 -IIA (1:50); sPLA 2 -IIC (1:100); sPLA 2 -IID (1:100); sPLA 2 -IIE (1:50); sPLA 2 -IIF (1:80); sPLA 2 -V 1:80); sPLA 2 -X (1:80); sPLA 2 -XII (1:50).
For negative control, sections were incubated with 2% bovine serum albumin without the primary antibody. The sections were then rinsed three times with PBS and incubated at room temperature for 35 min with an alkaline phosphatase-conjugated goat anti-rabbit IgG secondary antibody diluted 1:80 for all sPLA 2 subtypes in 2% bovine serum albumin.
Sections were rinsed as described above, and the alkaline phosphatase was stained using the DAKO fast red substrate-chromogen system, containing fast red tablets, bu¡ered substrate, and levamisole. The staining time, depending on the dilution of the antibodies and sPLA 2 subtypes, was controlled by microscopic observation. Phosphatase-labeled sections were counterstained with hematoxylin.
Data presentation The preparations of primary keratinocytes and the in vitro experiments were performed four times with four independent series of neonatal mice (about 50 animals per series). For immunohistochemical analysis of each sPLA 2 subtype, skin sections from at least ¢ve di¡erent animals were used.
RESULTS
First, we investigated the expression of sPLA 2 mRNA in neonatal mouse epidermis, a model system for hyperproliferative skin (Fˇrstenberger et al, 1985) . Neonatal epidermis can be separated into four di¡erent layers by discontinuous density gradient centrifugation (Schweizer et al, 1984) to give cells from stratum basale (N4), stratum spinosum (N3), stratum granulosum/corneum (N2), and upper stratum corneum (N1). The occurrence of sPLA 2 enzymes in keratinocytes fractionated according to their state of di¡erentiation in the di¡erent epidermal layers was investigated. mRNA for sPLA 2 -IB, sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII-2 were found to be present in keratinocytes from the upper, di¡er-entiated cell layers, i.e., in N1 and in N2, whereas these sPLA 2 s are barely detectable or even absent in basal keratinocytes from fractions N3 and N4 (Fig 1A) . sPLA 2 -IIE and sPLA 2 -XII-1 are nearly equally well expressed in N1, N2, and N3, but weakly in N4.
In contrast, mRNA for sPLA 2 -IIA, sPLA 2 -IID, and sPLA 2 -X was present at higher levels in keratinocytes from N3 and N4 compared with cells from N1 and N2 (Fig 1B) . sPLA 2 -IIC mRNA did not change across the di¡erent layers of neonatal epidermis (Fig 1C) .
To obtain information about the in vivo protein localization of the di¡erent sPLA 2 s, we performed an immunohistochemical analysis on para⁄n sections of neonatal mouse back skin. Immunostaining of sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII is detectable mainly in the suprabasal and uppermost layers of the interfollicular epidermis (Fig 2) . The basal layer consisting of proliferating keratinocytes was free of these enzymes. The negative control without primary antibody was devoid of staining (Fig 2) .
A clearly di¡erent expression pattern was found for sPLA 2 -IIA, sPLA 2 -IID, and sPLA 2 -X (Fig 3) . These enzymes are mainly detectable in cells of the basal layer of interfollicular and follicular epidermis. These results correspond to the mRNA expression seen in basal keratinocyte fractions (Fig 1A,B) . The other sPLA 2 Figure 1 . mRNA expression of sPLA 2 subtypes expressed in the four fractions of the epidermis of neonatal NMRI mice. Total RNA was extracted from cells of the four di¡erent epidermal layers N1^N4 obtained by density gradient centrifugation. Semiquantitative reverse transcriptionP CR was performed with speci¢c primers for each subtype as described in Materials and Methods. GAPDH was used as an internal standard. (A) mRNA expression of sPLA 2 -IB, sPLA 2 -IIE, sPLA 2 -IIF, sPLA 2 -V, sPLA 2 -XII-1, and sPLA 2 -XII-2, which are upregulated during di¡erentiation. (B) mRNA expression of sPLA 2 -IIA, sPLA 2 -IID, and sPLA 2 -X, which are downregulated during di¡erentiation. (C) mRNA expression of sPLA 2 -IIC, which is not regulated. Abbreviations: N4, stratum basale; N3, stratum spinosum; N2, stratum granulosum; N1, stratum corneum; n.t., no template. A representative of four independent experiments with similar results is shown. Figure 2 . Immunohistochemistry of sPLA 2 subtypes that are mainly expressed in the di¡erentiated layers of murine neonatal epidermis. Para⁄n-embedded sections of NMRI neonatal back skin were depara⁄nized and incubated with speci¢c primary antibodies against sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -X as described in Materials and Methods (original magni¢cation Â 40). Dilutions were used as follows: sPLA 2 -IIF and sPLA 2 -V 1:80; sPLA 2 -XII 1:50. After incubation with an alkaline phosphatase-conjugated IgG secondary antibody diluted 1:80, the sections were stained with the Dako fast red substrate-chromogenic system. Negative control corresponds to a stained skin section without primary antibody.
proteins (IB, IIC, IIE) seem to be expressed weakly throughout the interfollicular epidermis (Fig 4) . A comparable distribution of the di¡erent epidermal sPLA 2 s was detected in cross-sections of the tails of adult NMRI mice (data not shown).
For studying the regulation of sPLA 2 s during keratinocyte differentiation, primary keratinocytes from N3 and N4 were cultured under low or high Ca 2 þ conditions to either maintain the proliferation of keratinocytes (0.05 mM) or to induce their di¡er-entiation (1 mM; Hennings et al, 1980) . After di¡erent incubation periods, cells were analyzed for mRNA expression of the di¡er-ent sPLA 2 subtypes. Fig 5(A) , a shift to high Ca 2 þ concentration induced an upregulation of mRNA for sPLA 2 -IB, sPLA 2 -IID, sPLA 2 -IIE, sPLA 2 -IIF, and sPLA 2 -XII-1 with steady-state levels at 8 h, whereas the sPLA 2 -V mRNA level increased only at 24 h after the Ca 2 þ shift. At later time points, the mRNA levels for sPLA 2 -IID, sPLA 2 -IIE, and sPLA 2 -V decreased, whereas those for sPLA 2 -IB, sPLA 2 -IIF, and sPLA 2 -XII-1 remain elevated up to 72 h sPLA 2 -IB was barely detectable after 72 h.
As shown in
In contrast, mRNA for sPLA 2 -IIA and sPLA 2 -X were detected under low Ca 2 þ conditions and were found to be reduced after the Ca 2 þ shift (Fig 6A) . Immunohistochemistry of sPLA 2 subtypes that are constitutively expressed in the murine epidermis. After depara⁄nization, the sections of NMRI neonatal back skin were incubated with speci¢c primary antibodies against sPLA 2 -IB, sPLA 2 -IIC, and sPLA 2 -IIE with a dilution of 1:50 for sPLA 2 -IB and sPLA 2 -IIE and 1:100 for sPLA 2 -IIC as described in Materials and Methods. After incubation with an alkaline phosphatase-conjugated IgG secondary antibody diluted 1:80, the sections were stained as described in Fig 2 (original magni¢cation Â 40) .
The mRNA steady-state level of sPLA 2 -IIC remained unchanged in all conditions (Fig 6A) .
Despite the detection of the mRNA for sPLA 2 -XII-2 in the cell fraction N2 after density centrifugation (Fig 1A) , the mRNA for this subtype was not detectable in primary keratinocytes under low or high calcium (data not shown). This suggests that in vivo in neonatal epidermis, sPLA 2 -XII-2 mRNA is expressed in a cell type di¡erent from keratinocytes.
Using sPLA 2 subtype-speci¢c antibodies, a similar di¡eren-tiation-dependent expression pattern was found in western Figure 5 . Reverse transcription^PCR (A) and western blot analysis (B) of sPLA 2 expression in murine primary keratinocytes, which are upregulated after Ca 2 þ shift. Primary keratinocytes were obtained by density gradient centrifugation and cultured under di¡erent Ca 2 þ concentrations as described in Materials and Methods. The cells were harvested for RNA and protein extraction after the indicated time points. (A) DNA-free RNA was reverse transcribed and subjected to semiquantitative PCR analysis with primer sets speci¢c for sPLA 2 -IB, sPLA 2 -IID, sPLA 2 -IIE, sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII-1. Each of these sPLA 2 are upregulated after shifting the Ca 2+ concentration in the cell culture medium to 1.0 mM. GAPDH was used as an internal standard. (B) Protein expression of the indicated sPLA 2 subtypes was analyzed by probing 50 mg of total protein on western blots, which were incubated with speci¢c antibodies against each subtype in a dilution of 1:150. Abbreviations: n.t., no template; MW, molecular weight marker. Data are representative of four independent studies with comparable results. Figure 6 . Semiquantitative reverse transcription^PCR and western blot analysis of sPLA 2 mRNA and protein expression in murine primary keratinocytes that are downregulated after Ca 2 þ shift. Primary keratinocytes were obtained and cultured as described in Fig 5. (A) DNA-free RNA was reverse transcribed and subjected to PCR analysis with primer sets speci¢c for sPLA 2 -IIA, sPLA 2 -IIC, and sPLA 2 -X. GAPDH was used as an internal standard. (B), Protein expression of sPLA 2 -IIA, sPLA 2 -IIC, and sPLA 2 -X was obtained as described in Fig 5. Abbreviations: n.t., no template; MW, molecular weight marker. Data are representative of four independent studies with comparable results.
blots from keratinocytes cultured under low or high Ca 2+ conditions. For each of these anti-sera, 1 ng of the respective mouse sPLA 2 is readily detected (ECL detection) without giving a signal for all of the other mouse enzymes when tested at 50 ng.
Consistent with the mRNA levels (Fig 5A) , sPLA 2 -IB, sPLA 2 -IID, sPLA 2 -IIE, sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII proteins are weakly expressed in keratinocytes cultured in low Ca 2+ medium and increased markedly 8 h after induction of differentiation (Fig 5B) . At later time points (48 and 72 h) the protein levels decreased.
In contrast, strong expression of sPLA 2 -IIA and sPLA 2 -X protein was detected in low Ca 2+ medium, and that of sPLA 2 -X even increased 8 h after the Ca 2+ shift; however, 24 h after Ca 2+ shift the protein levels were markedly reduced (Fig 6B) . The protein expression pattern for sPLA 2 -IIC did not appear to ¢t with the mRNA expression. Indeed, sPLA 2 -IIC was mainly found in the basal layer and was decreased in high Ca 2 þ medium ( Fig 6B) . As the mRNA expression appears constant in all conditions (Fig 6A) , the observed decrease in sPLA 2 -IIC protein expression in vivo suggests a decrease in protein stability.
DISCUSSION
This study shows that in neonatal mouse epidermis murine group I, II, V, X, and XII sPLA 2 subtypes are expressed at the mRNA and protein levels. Interestingly, distinct sPLA 2 subsets are expressed in the basal epidermal layer and in the upper di¡er-entiated layers. In vitro, the regulation of sPLA 2 mRNA and protein expression appears to be strongly dependent on the Ca 2+ concentration as found in cultures of primary keratinocytes isolated from neonatal NMRI mice. sPLA 2 s expressed in the basal layer were those found to be expressed under low Ca 2+ conditions (0.05 mM), whereas sPLA 2 s expressed in the suprabasal layers was detected after Ca 2+ increase (1 mM). One proposed physiologic function of sPLA 2 s in the normal skin is that one or more of these enzymes play a part in the formation of the epidermal permeability barrier by hydrolyzing polar phospholipids, thus generating free fatty acids at the stratum granulosum/stratum corneum border (Schˇrer and Elias, 1991) . It is, however, still unclear, which sPLA 2 contribute to barrier function. In studies by Mao-Qiang et al (1995) and Fluhr et al (2001) using p-bromophenacyl bromide as a general sPLA 2 inhibitor and MJ33 as an active-site directed sPLA 2 inhibitor, it was proposed that sPLA 2 -IB contributes to barrier formation; however, p-bromophenacyl bromide most likely inhibits several mouse sPLA 2 because it alkylates the active site histidine that is conserved in all sPLA 2 s, and MJ33 has recently been shown to inhibit most of the mouse group I, II, V, and X sPLA 2 s (Singer et al, 2002) . Thus, the speci¢c sPLA 2 involved in barrier formation remains to be established. Further investigations with more speci¢c inhibitors as well as detailed localization studies are necessary to determine which of the sPLA 2 s subtypes are present in lamellar bodies where they may contribute to fatty acid release for physiologic barrier functions.
In this study, we have detected mRNA expression for sPLA 2 -IB, sPLA 2 -IIE, sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII-1/-2 in keratinocytes isolated from the di¡erentiated layers (N1 and N2) of neonatal epidermis by density gradient centrifugation. Thus, one or more of these sPLA 2 appears to be a potential candidate for generating free fatty acids from phospholipids for formation of the permeability barrier.
The distribution of mRNA for sPLA 2 -IB, sPLA 2 -IIE, sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII in the di¡erent layers was similar at the mRNA and protein levels in primary keratinocytes grown in culture and di¡erentiated with Ca 2+ (Hennings et al, 1989; Yuspa et al, 1989) . Interestingly, sPLA 2 -XII-2 mRNA is found in the cell fraction N2, but is not expressed in primary keratinocytes under any conditions studied. sPLA 2 -XII-2 was so far only found in T helper type 2 cells (Ho et al, 2001) , and thus it is possible that a cell type other than keratinocytes, being present in the N2 fraction after density gradient centrifugation, might express mRNA for this sPLA 2 subtype; however, it should also be mentioned that there are no reports showing the existence of mouse sPLA 2 -XII-2 protein.
Immunohistochemical studies in para⁄n sections of the back skin of neonatal mice support a suprabasal expression of sPLA 2 -IIF, sPLA 2 -V, and sPLA 2 -XII protein in vivo. sPLA 2 -IB and sPLA 2 -IIE, which are also upregulated after the Ca 2+ shift, appeared to be weakly expressed throughout the interfollicular epidermis. From these results, we suggest that not only sPLA 2 -IB, but also sPLA 2 subtypes IIF, V, and XII, which are expressed in the uppermost layers, may be involved in barrier function. A more detailed localization study and the use of group speci¢c sPLA 2 inhibitors are necessary to unravel which sPLA 2 subtypes are present in lamellar bodies and contribute to fatty acid release for physiologic barrier functions.
A di¡erent expression pattern of sPLA 2 subtypes was obvious in keratinocytes from the basal layer. By performing immunohistochemical staining, we have observed a speci¢c basal expression of sPLA 2 -IIA, sPLA 2 -IID, and sPLA 2 -X in vivo. Interestingly, in the Ca 2+ experiments in vitro, sPLA 2 -IID and sPLA 2 -X show an additional upregulation 8 h after calcium shift. As the Ca 2+ -mediated increase in sPLA 2 -IID and sPLA 2 -X protein expression occurs during a relatively early time period after the start of di¡er-entiation, we suggested that the cells expressing sPLA 2 -IID and sPLA 2 -X still reside in the basal layer and have not yet moved upwards to suprabasal cell layers. Similarly, a subpopulation of basal keratinocytes was shown to express the ''suprabasal'' keratin 10, a marker protein of terminal di¡erentiation (Schweizer et al, 1984) . Interestingly, sPLA 2 -IIC, which was found at high level in testis and as a pseudogene in humans (Tisch¢eld et al, 1996; Chen et al, 1997) , is expressed at the protein level in proliferating primary keratinocytes in vitro, whereas it is found in vivo in the entire epidermis by immunochemical staining. The decrease in protein levels during terminal di¡erentiation might be due to a more rapid degradation in vitro as compared with the in vivo situation.
The strong expression of sPLA 2 -IIA, sPLA 2 -IID, and sPLA 2 -X proteins in the basal layer raises questions regarding their functions in this layer. Interestingly, mouse sPLA 2 -IIA, which was ¢rst identi¢ed as enhancing factor (Mulherkar et al, 1993) , was also found in proliferating cells in the skin and in Paneth cells of the small intestine (Desai et al, 1991) . The enhancing factor had the property to enhance the binding of epidermal growth factor to its receptor in the epidermoid carcinoma cell line A431 (Mulherkar et al, 1993) , suggesting a role of sPLA 2 -IIA, and possibly of other sPLA 2 proteins, in hyperproliferation of keratinocytes. Moreover, the murine sPLA 2 enzymes are potentially able to release arachidonic acid (Singer et al, 2002) , and thus, they might be involved in eicosanoid homeostasis. Mouse sPLA 2 -X can release free fatty acids, including arachidonic acid from adherent cells (Hanasaki et al, 1999; Murakami et al, 1999; Bezzine et al, 2000; Morioka et al, 2000a, b; Saiga et al, 2001) , suggesting that this enzyme may signi¢cantly contribute to eicosanoid formation. sPLA 2 -IIA as well as sPLA 2 -IID may also release arachidonic acid from stimulated cells via heparanoid binding (Murakami et al, 1999 (Murakami et al, , 2002a ; for review, see Kudo and Murakami, 2002) . Thus, regarding potential functions of basally expressed sPLA 2 , it is tempting to speculate that they might be involved in keratinocyte hyperproliferation during in£ammatory processes. On the other hand, because of their broad substrate speci¢city, sPLA 2 s may also produce fatty acids, such as linoleic acid and some of its metabolites, which in turn promote anti-in£amma-tory functions and oppose their e¡ects to those of cPLA 2 s and its lipid mediator products (Buckley et al, 1992; Fischer et al, 1996) .
We have observed that the expression of some sPLA 2 s is modulated in vitro after changing the Ca 2+ concentrations of the medium (sPLA 2 -IB, sPLA 2 -IIC, and sPLA 2 -IIE), whereas there was no di¡erence in protein expression detectable in immunohistochemical staining in epidermis in vivo. The reason for this discrepancy is currently unknown, but there might be some additional regulatory factors or di¡erences in mRNA or protein stability in vivo, which cannot be mimicked in keratinocyte cultures by Ca 2+ shift. Furthermore, it cannot be excluded that other sPLA 2 subtypes, which are expressed at low level in the basal layer of normal neonatal skin, may be upregulated under in£ammatory conditions. In this respect, a recent study showed an increased mRNA expression of sPLA 2 -IIF in atopic dermatitis induced in the mouse ear, whereas in normal murine skin, the mRNA for this sPLA 2 was not detected (Murakami et al, 2002b) . In this study, we could clearly show that in normal murine skin, sPLA 2 -IIF mRNA and protein expression is found mainly in di¡erentiated keratinocytes. Further studies focusing on the protein expression of sPLA 2 -IIF in in£amed mouse skin are mandatory. In other studies, mRNA expression of sPLA 2 -IID and sPLA 2 -IIE was found to be upregulated in mice with experimental atopic dermatitis, but again protein studies are lacking (Murakami et al, 2002a, c) .
The functional role of certain sPLA 2 subtypes for eicosanoid biosynthesis in the skin under in£ammatory conditions in vivo and in vitro remains to be determined. Interestingly, the di¡eren-tiation-dependent expression of sPLA 2 subtypes correlated with the expression pattern of eicosanoid-generating enzymes. The expression of the individual cyclooxygenase-1/2 and lipoxygenase enzymes in mouse epidermis was also found to be dependent on the terminal di¡erentiation of keratinocytes (Mˇller-Decker et al, 1998; Heidt et al, 2000) . Thus, a concerted action of distinct sPLA 2 subtypes with individual cyclooxygenase or lipoxygenase isozymes may generate distinct patterns of eicosanoids being involved in autocrine or paracrine e¡ects of the autacoids. Moreover, it has to be considered that murine sPLA 2 s might be secreted and may act in a paracrine fashion on keratinocytes of other epidermal layers by mediating signal transduction via the M-type sPLA 2 receptor (Cupillard et al, 1999; Yokota et al, 2000) .
In summary, we have described a speci¢c expression pattern for group I, II, V, X, and XII sPLA 2 s in murine skin. This pattern is related to the regulation of growth and di¡erentiation, and suggest distinct functions for each sPLA 2 subtype in epidermal homeostasis under both normal and pathologic conditions.
